CD8A and glioblastoma: This CD28− CD8+ Foxp3+ subset, found in many cancers, has also been identified in the TME of GBM patients, and it amplifies the immunosuppression mediated by T regulatory (reg) cells, thus contributing to the dysfunction of dendritic cells (DCs) [103,106,107,108].